1822, 39, [1]
Book
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2015, Volume 2015, Issue 7, p. CD000371
Background The World Health Organization (WHO) recommends treating all school children at regular intervals with deworming drugs in areas where helminth...
Humans | MULTI-MICRONUTRIENT SUPPLEMENTATION | RANDOMIZED CONTROLLED-TRIAL | Growth [drug effects] | IRON SUPPLEMENTATION | Anthelmintics [pharmacology; therapeutic use] | TRICHURIS-TRICHIURA INFECTION | MEDICINE, GENERAL & INTERNAL | HELMINTH INFECTIONS | Nutritional Status [drug effects] | Helminthiasis [complications; drug therapy] | ASCARIS-LUMBRICOIDES INFECTIONS | Child | MALNOURISHED PRESCHOOL-CHILDREN | Soil [parasitology] | ANTHELMINTIC TREATMENT | Preschool | Cognition [drug effects] | Randomized Controlled Trials as Topic | Child Development [drug effects] | VITAMIN-A STATUS | Intestinal Diseases, Parasitic [complications; drug therapy] | Weight Gain [drug effects] | Adolescent | DOUBLE-BLIND | Hemoglobin A - drug effects | Soil - parasitology | Intestinal Diseases, Parasitic - drug therapy | Child, Preschool | Cognition - drug effects | Endemic Diseases | Growth - drug effects | Anthelmintics - pharmacology | Nutritional Status - drug effects | Helminthiasis - complications | Weight Gain - drug effects | Child Development - drug effects | Helminthiasis - drug therapy | Anthelmintics - therapeutic use | Intestinal Diseases, Parasitic - complications
Humans | MULTI-MICRONUTRIENT SUPPLEMENTATION | RANDOMIZED CONTROLLED-TRIAL | Growth [drug effects] | IRON SUPPLEMENTATION | Anthelmintics [pharmacology; therapeutic use] | TRICHURIS-TRICHIURA INFECTION | MEDICINE, GENERAL & INTERNAL | HELMINTH INFECTIONS | Nutritional Status [drug effects] | Helminthiasis [complications; drug therapy] | ASCARIS-LUMBRICOIDES INFECTIONS | Child | MALNOURISHED PRESCHOOL-CHILDREN | Soil [parasitology] | ANTHELMINTIC TREATMENT | Preschool | Cognition [drug effects] | Randomized Controlled Trials as Topic | Child Development [drug effects] | VITAMIN-A STATUS | Intestinal Diseases, Parasitic [complications; drug therapy] | Weight Gain [drug effects] | Adolescent | DOUBLE-BLIND | Hemoglobin A - drug effects | Soil - parasitology | Intestinal Diseases, Parasitic - drug therapy | Child, Preschool | Cognition - drug effects | Endemic Diseases | Growth - drug effects | Anthelmintics - pharmacology | Nutritional Status - drug effects | Helminthiasis - complications | Weight Gain - drug effects | Child Development - drug effects | Helminthiasis - drug therapy | Anthelmintics - therapeutic use | Intestinal Diseases, Parasitic - complications
Journal Article
1970, 76
Book
1962, Technical Communication, no. 33 of the Commonwealth Bureau of Helminthology, St. Albans, Herts, 172
Book
1930, 102
Book
Veterinary Parasitology, ISSN 0304-4017, 05/2012, Volume 186, Issue 1-2, pp. 70 - 78
Over the past 10–15 years, we have witnessed a rapid increase in both the prevalence and magnitude of anthelmintic resistance, and this increase appears to be...
Anthelmintic resistance | Horses | Nematodes | Sheep | Goats | Cattle | IVERMECTIN RESISTANCE | NEW-ZEALAND | GASTROINTESTINAL NEMATODES | BETA-TUBULIN GENE | PARASCARIS-EQUORUM | MACROCYCLIC LACTONE ANTHELMINTICS | SHEEP FARMS | HORSE FARMS | VETERINARY SCIENCES | BENZIMIDAZOLE RESISTANCE | PARASITOLOGY | OSTERTAGIA-CIRCUMCINCTA | Prevalence | Sheep Diseases - parasitology | Nematode Infections - drug therapy | Sheep Diseases - drug therapy | Parasite Egg Count - veterinary | Nematoda - drug effects | Global Warming | Animals | Anthelmintics - pharmacology | Feces - parasitology | Nematode Infections - epidemiology | Nematode Infections - parasitology | Nematode Infections - veterinary | Female | Livestock | Sheep Diseases - epidemiology | Anthelmintics - therapeutic use | Drug Resistance | New Zealand - epidemiology | Veterinary supplies industry | Analysis | Sustainable development | Ivermectin
Anthelmintic resistance | Horses | Nematodes | Sheep | Goats | Cattle | IVERMECTIN RESISTANCE | NEW-ZEALAND | GASTROINTESTINAL NEMATODES | BETA-TUBULIN GENE | PARASCARIS-EQUORUM | MACROCYCLIC LACTONE ANTHELMINTICS | SHEEP FARMS | HORSE FARMS | VETERINARY SCIENCES | BENZIMIDAZOLE RESISTANCE | PARASITOLOGY | OSTERTAGIA-CIRCUMCINCTA | Prevalence | Sheep Diseases - parasitology | Nematode Infections - drug therapy | Sheep Diseases - drug therapy | Parasite Egg Count - veterinary | Nematoda - drug effects | Global Warming | Animals | Anthelmintics - pharmacology | Feces - parasitology | Nematode Infections - epidemiology | Nematode Infections - parasitology | Nematode Infections - veterinary | Female | Livestock | Sheep Diseases - epidemiology | Anthelmintics - therapeutic use | Drug Resistance | New Zealand - epidemiology | Veterinary supplies industry | Analysis | Sustainable development | Ivermectin
Journal Article
Proceedings of the Royal Society B: Biological Sciences, ISSN 0962-8452, 02/2014, Volume 281, Issue 1780, p. 20132985
Gastrointestinal (GI) nematodes are among the most important causes of production loss in farmed ruminants, and anthelmintic resistance is emerging globally....
Anthelmintic resistance | Anthelmintics | Nematodes | Haemonchus contortus | Livestock | Deer | deer | NEW-ZEALAND | GASTROINTESTINAL NEMATODES | anthelmintics | RED DEER | nematodes | BEEF-CATTLE | CERVUS-ELAPHUS | EVOLUTIONARY BIOLOGY | HAEMONCHUS-CONTORTUS | DAIRY-COWS | DAMA-DAMA | anthelmintic resistance | FALLOW DEER | livestock | VETERINARY IMPORTANCE | BIOLOGY | ECOLOGY | Cattle - parasitology | Sheep Diseases - transmission | Cattle Diseases - transmission | Deer - parasitology | Sheep Diseases - parasitology | Genotype | Sheep - parasitology | Nematode Infections - transmission | Cattle Diseases - parasitology | Sheep Diseases - drug therapy | Nematoda - physiology | Nematoda - drug effects | Nematoda - genetics | Animals | Anthelmintics - pharmacology | Nematode Infections - veterinary | Cattle Diseases - drug therapy | Disease Vectors | Host-Parasite Interactions | Anthelmintics - therapeutic use | Drug Resistance | 1001 | 197
Anthelmintic resistance | Anthelmintics | Nematodes | Haemonchus contortus | Livestock | Deer | deer | NEW-ZEALAND | GASTROINTESTINAL NEMATODES | anthelmintics | RED DEER | nematodes | BEEF-CATTLE | CERVUS-ELAPHUS | EVOLUTIONARY BIOLOGY | HAEMONCHUS-CONTORTUS | DAIRY-COWS | DAMA-DAMA | anthelmintic resistance | FALLOW DEER | livestock | VETERINARY IMPORTANCE | BIOLOGY | ECOLOGY | Cattle - parasitology | Sheep Diseases - transmission | Cattle Diseases - transmission | Deer - parasitology | Sheep Diseases - parasitology | Genotype | Sheep - parasitology | Nematode Infections - transmission | Cattle Diseases - parasitology | Sheep Diseases - drug therapy | Nematoda - physiology | Nematoda - drug effects | Nematoda - genetics | Animals | Anthelmintics - pharmacology | Nematode Infections - veterinary | Cattle Diseases - drug therapy | Disease Vectors | Host-Parasite Interactions | Anthelmintics - therapeutic use | Drug Resistance | 1001 | 197
Journal Article
Nature, ISSN 0028-0836, 03/2008, Volume 452, Issue 7184, pp. 176 - 180
Anthelmintic resistance in human and animal pathogenic helminths has been spreading in prevalence and severity to a point where multidrug resistance against...
HAEMONCHUS-CONTORTUS | CAENORHABDITIS-ELEGANS | HELMINTHS | EFFICACY | MULTIDISCIPLINARY SCIENCES | IVERMECTIN | ACETYLCHOLINE-RECEPTOR SUBUNITS | GHANA | LIVESTOCK | Parasitic Diseases, Animal - parasitology | Aminoacetonitrile - analogs & derivatives | Caenorhabditis elegans Proteins - chemistry | Sheep Diseases - parasitology | Caenorhabditis elegans Proteins - metabolism | Molecular Sequence Data | Sheep - parasitology | Cattle Diseases - parasitology | Receptors, Nicotinic - chemistry | Cattle | Larva - drug effects | Aging | Cattle Diseases - drug therapy | Larva - genetics | Anthelmintics - pharmacokinetics | Amino Acid Sequence | Receptors, Nicotinic - metabolism | Caenorhabditis elegans - metabolism | Caenorhabditis elegans - genetics | Anthelmintics - chemistry | Sheep Diseases - drug therapy | Nematoda - physiology | Nematoda - drug effects | Parasitic Diseases, Animal - drug therapy | Anthelmintics - classification | Drug Resistance - genetics | Nematoda - genetics | Animals | Caenorhabditis elegans - drug effects | Aminoacetonitrile - adverse effects | Aminoacetonitrile - pharmacokinetics | Anthelmintics - pharmacology | Aminoacetonitrile - pharmacology | Caenorhabditis elegans Proteins - genetics | Receptors, Nicotinic - genetics | Pathology | Livestock | Drug resistance | Drug therapy | Worms | Index Medicus
HAEMONCHUS-CONTORTUS | CAENORHABDITIS-ELEGANS | HELMINTHS | EFFICACY | MULTIDISCIPLINARY SCIENCES | IVERMECTIN | ACETYLCHOLINE-RECEPTOR SUBUNITS | GHANA | LIVESTOCK | Parasitic Diseases, Animal - parasitology | Aminoacetonitrile - analogs & derivatives | Caenorhabditis elegans Proteins - chemistry | Sheep Diseases - parasitology | Caenorhabditis elegans Proteins - metabolism | Molecular Sequence Data | Sheep - parasitology | Cattle Diseases - parasitology | Receptors, Nicotinic - chemistry | Cattle | Larva - drug effects | Aging | Cattle Diseases - drug therapy | Larva - genetics | Anthelmintics - pharmacokinetics | Amino Acid Sequence | Receptors, Nicotinic - metabolism | Caenorhabditis elegans - metabolism | Caenorhabditis elegans - genetics | Anthelmintics - chemistry | Sheep Diseases - drug therapy | Nematoda - physiology | Nematoda - drug effects | Parasitic Diseases, Animal - drug therapy | Anthelmintics - classification | Drug Resistance - genetics | Nematoda - genetics | Animals | Caenorhabditis elegans - drug effects | Aminoacetonitrile - adverse effects | Aminoacetonitrile - pharmacokinetics | Anthelmintics - pharmacology | Aminoacetonitrile - pharmacology | Caenorhabditis elegans Proteins - genetics | Receptors, Nicotinic - genetics | Pathology | Livestock | Drug resistance | Drug therapy | Worms | Index Medicus
Journal Article
International Journal for Parasitology, ISSN 0020-7519, 2010, Volume 40, Issue 1, pp. 1 - 13
Helminth infections are an important constraint on the health and development of poor children and adults. Anthelmintic treatment programmes provide a safe and...
Schistosomiasis | Mass drug administration | Anthelmintics | Pharmacology | Soil-transmitted helminths | Onchocerciasis | Lymphatic filariasis | BETA-TUBULIN | WUCHERERIA-BANCROFTI | ONCHOCERCA-VOLVULUS | DRUG-RESISTANCE | INTESTINAL NEMATODE INFECTIONS | IN-VITRO | DIETHYLCARBAMAZINE DEC | VETERINARY IMPORTANCE | SOIL-TRANSMITTED HELMINTHIASIS | PARASITOLOGY | Humans | Child, Preschool | Helminthiasis - parasitology | Animals | Anthelmintics - pharmacology | Drug Design | Adult | Female | Developing Countries | Helminthiasis - drug therapy | Anthelmintics - therapeutic use | Child | Drug Resistance | Anthelmintics - adverse effects | Universities and colleges | Veterinary supplies industry | Public health
Schistosomiasis | Mass drug administration | Anthelmintics | Pharmacology | Soil-transmitted helminths | Onchocerciasis | Lymphatic filariasis | BETA-TUBULIN | WUCHERERIA-BANCROFTI | ONCHOCERCA-VOLVULUS | DRUG-RESISTANCE | INTESTINAL NEMATODE INFECTIONS | IN-VITRO | DIETHYLCARBAMAZINE DEC | VETERINARY IMPORTANCE | SOIL-TRANSMITTED HELMINTHIASIS | PARASITOLOGY | Humans | Child, Preschool | Helminthiasis - parasitology | Animals | Anthelmintics - pharmacology | Drug Design | Adult | Female | Developing Countries | Helminthiasis - drug therapy | Anthelmintics - therapeutic use | Child | Drug Resistance | Anthelmintics - adverse effects | Universities and colleges | Veterinary supplies industry | Public health
Journal Article
Veterinary Parasitology, ISSN 0304-4017, 01/2017, Volume 234, pp. 40 - 48
Nematodicidal combinations have been proposed as a valid strategy to achieve effective nematode control in the presence of drug resistance. The goals of this...
Nematodicidal combination | Anthelmintic resistance | Pharmacokinetic interaction | Ricobendazole | Pharmaco-parasitological assessment | Ivermectin | MANAGING ANTHELMINTIC RESISTANCE | WORLD-ASSOCIATION | EFFICACY | LAMBS | GASTROINTESTINAL NEMATODES | ALBENDAZOLE | ARGENTINA | SUSTAINABLE CONTROL | SHEEP NEMATODES | VETERINARY SCIENCES | PARASITOLOGY | LEVAMISOLE | Male | Cattle Diseases - parasitology | Drug Interactions | Cattle | Nematode Infections - veterinary | Albendazole - pharmacology | Cattle Diseases - drug therapy | Anthelmintics - pharmacokinetics | Drug Therapy, Combination | Albendazole - analogs & derivatives | Anthelmintics - therapeutic use | Albendazole - pharmacokinetics | Albendazole - blood | Albendazole - therapeutic use | Ivermectin - therapeutic use | Ivermectin - pharmacokinetics | Treatment Outcome | Drug Resistance - drug effects | Ivermectin - pharmacology | Nematode Infections - drug therapy | Random Allocation | Parasite Egg Count - veterinary | Anthelmintics - blood | Animals | Anthelmintics - pharmacology | Nematode Infections - parasitology | Ivermectin - blood | Nematoda | Health aspects | Analysis | Drug resistance | Epidemiology
Nematodicidal combination | Anthelmintic resistance | Pharmacokinetic interaction | Ricobendazole | Pharmaco-parasitological assessment | Ivermectin | MANAGING ANTHELMINTIC RESISTANCE | WORLD-ASSOCIATION | EFFICACY | LAMBS | GASTROINTESTINAL NEMATODES | ALBENDAZOLE | ARGENTINA | SUSTAINABLE CONTROL | SHEEP NEMATODES | VETERINARY SCIENCES | PARASITOLOGY | LEVAMISOLE | Male | Cattle Diseases - parasitology | Drug Interactions | Cattle | Nematode Infections - veterinary | Albendazole - pharmacology | Cattle Diseases - drug therapy | Anthelmintics - pharmacokinetics | Drug Therapy, Combination | Albendazole - analogs & derivatives | Anthelmintics - therapeutic use | Albendazole - pharmacokinetics | Albendazole - blood | Albendazole - therapeutic use | Ivermectin - therapeutic use | Ivermectin - pharmacokinetics | Treatment Outcome | Drug Resistance - drug effects | Ivermectin - pharmacology | Nematode Infections - drug therapy | Random Allocation | Parasite Egg Count - veterinary | Anthelmintics - blood | Animals | Anthelmintics - pharmacology | Nematode Infections - parasitology | Ivermectin - blood | Nematoda | Health aspects | Analysis | Drug resistance | Epidemiology
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 11/2014, Volume 22, Issue 21, pp. 6297 - 6304
We studied the antischistosomal activity of betulin, betulinic acid and its 9 triphenylphosphonium derivatives characterized by a covalently linkage of the...
Schistosoma mansoni | In vivo | Betulin | Triphenylphosphonium compounds | In vitro | Betulinic acid | In vitro In vivo | LUPANE TRITERPENOIDS | CHEMISTRY, MEDICINAL | PHOSPHONIUM SALTS | ANTHELMINTIC ACTIVITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, ORGANIC | Schistosoma mansoni - drug effects | Organophosphorus Compounds - chemical synthesis | Triterpenes - pharmacology | Humans | Triterpenes - therapeutic use | Organophosphorus Compounds - therapeutic use | Anthelmintics - chemical synthesis | Organophosphorus Compounds - chemistry | Anthelmintics - chemistry | Schistosomiasis mansoni - drug therapy | Triterpenes - chemistry | Animals | Schistosomiasis mansoni - parasitology | Triterpenes - chemical synthesis | Anthelmintics - pharmacology | Organophosphorus Compounds - pharmacology | Female | Mice | Anthelmintics - therapeutic use
Schistosoma mansoni | In vivo | Betulin | Triphenylphosphonium compounds | In vitro | Betulinic acid | In vitro In vivo | LUPANE TRITERPENOIDS | CHEMISTRY, MEDICINAL | PHOSPHONIUM SALTS | ANTHELMINTIC ACTIVITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, ORGANIC | Schistosoma mansoni - drug effects | Organophosphorus Compounds - chemical synthesis | Triterpenes - pharmacology | Humans | Triterpenes - therapeutic use | Organophosphorus Compounds - therapeutic use | Anthelmintics - chemical synthesis | Organophosphorus Compounds - chemistry | Anthelmintics - chemistry | Schistosomiasis mansoni - drug therapy | Triterpenes - chemistry | Animals | Schistosomiasis mansoni - parasitology | Triterpenes - chemical synthesis | Anthelmintics - pharmacology | Organophosphorus Compounds - pharmacology | Female | Mice | Anthelmintics - therapeutic use
Journal Article
Current Opinion in Infectious Diseases, ISSN 0951-7375, 12/2012, Volume 25, Issue 6, pp. 709 - 717
PURPOSE OF REVIEWAnthelmintic mass drug administration (MDA) has limited pathology and transmission of filariases, schistosomiasis and gastrointestinal...
anthelmintic | anthelmintic resistance | helminth elimination | drug donation | DOXYCYCLINE TREATMENT | INFECTIOUS DISEASES | SOIL-TRANSMITTED HELMINTHS | WUCHERERIA-BANCROFTI | RANDOMIZED CONTROLLED-TRIAL | ONCHOCERCA-VOLVULUS | RESEARCH AGENDA | PREVENTIVE CHEMOTHERAPY | LYMPHATIC FILARIASIS | NEGLECTED TROPICAL DISEASES | MACROFILARICIDAL ACTIVITY | Disease Eradication | Animals | Drug Administration Schedule | Helminths - drug effects | Anthelmintics - pharmacology | Humans | Treatment Outcome | Anthelmintics - pharmacokinetics | Helminthiasis - drug therapy | Anthelmintics - administration & dosage | Drug Resistance
anthelmintic | anthelmintic resistance | helminth elimination | drug donation | DOXYCYCLINE TREATMENT | INFECTIOUS DISEASES | SOIL-TRANSMITTED HELMINTHS | WUCHERERIA-BANCROFTI | RANDOMIZED CONTROLLED-TRIAL | ONCHOCERCA-VOLVULUS | RESEARCH AGENDA | PREVENTIVE CHEMOTHERAPY | LYMPHATIC FILARIASIS | NEGLECTED TROPICAL DISEASES | MACROFILARICIDAL ACTIVITY | Disease Eradication | Animals | Drug Administration Schedule | Helminths - drug effects | Anthelmintics - pharmacology | Humans | Treatment Outcome | Anthelmintics - pharmacokinetics | Helminthiasis - drug therapy | Anthelmintics - administration & dosage | Drug Resistance
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 7, Issue 7, p. CD000371
Background The World Health Organization (WHO) recommends treating all school children at regular intervals with deworming drugs in areas where helminth...
Humans | ANTHELMINTIC TREATMENT | MULTI-MICRONUTRIENT SUPPLEMENTATION | Child, Preschool | Cognition [drug effects] | RANDOMIZED CONTROLLED-TRIAL | Growth [drug effects] | IRON SUPPLEMENTATION | Anthelmintics [pharmacology; therapeutic use] | Randomized Controlled Trials as Topic | TRICHURIS-TRICHIURA INFECTION | MEDICINE, GENERAL & INTERNAL | Child Development [drug effects] | VITAMIN-A STATUS | Intestinal Diseases, Parasitic [complications; drug therapy] | Weight Gain [drug effects] | HELMINTH INFECTIONS | Nutritional Status [drug effects] | Adolescent | DOUBLE-BLIND | Helminthiasis [complications; drug therapy] | ASCARIS-LUMBRICOIDES INFECTIONS | Child | MALNOURISHED PRESCHOOL-CHILDREN | Soil - parasitology | Intestinal Diseases, Parasitic - drug therapy | Cognition - drug effects | Growth - drug effects | Anthelmintics - pharmacology | Nutritional Status - drug effects | Helminthiasis - complications | Weight Gain - drug effects | Child Development - drug effects | Helminthiasis - drug therapy | Anthelmintics - therapeutic use | Intestinal Diseases, Parasitic - complications
Humans | ANTHELMINTIC TREATMENT | MULTI-MICRONUTRIENT SUPPLEMENTATION | Child, Preschool | Cognition [drug effects] | RANDOMIZED CONTROLLED-TRIAL | Growth [drug effects] | IRON SUPPLEMENTATION | Anthelmintics [pharmacology; therapeutic use] | Randomized Controlled Trials as Topic | TRICHURIS-TRICHIURA INFECTION | MEDICINE, GENERAL & INTERNAL | Child Development [drug effects] | VITAMIN-A STATUS | Intestinal Diseases, Parasitic [complications; drug therapy] | Weight Gain [drug effects] | HELMINTH INFECTIONS | Nutritional Status [drug effects] | Adolescent | DOUBLE-BLIND | Helminthiasis [complications; drug therapy] | ASCARIS-LUMBRICOIDES INFECTIONS | Child | MALNOURISHED PRESCHOOL-CHILDREN | Soil - parasitology | Intestinal Diseases, Parasitic - drug therapy | Cognition - drug effects | Growth - drug effects | Anthelmintics - pharmacology | Nutritional Status - drug effects | Helminthiasis - complications | Weight Gain - drug effects | Child Development - drug effects | Helminthiasis - drug therapy | Anthelmintics - therapeutic use | Intestinal Diseases, Parasitic - complications
Journal Article
Veterinary Parasitology, ISSN 0304-4017, 08/2018, Volume 260, pp. 38 - 44
The effective dose of an injectable prodrug, named compound alpha prodrug, against immature and adult Fasciola hepatica in experimentally infected sheep was...
Fasciola hepatica | Experimental water-soluble prodrug compound alpha | bioisostere | anthelmintics | TRICLABENDAZOLE RESISTANCE | INFECTED CATTLE | EFFICACY | IN-VITRO TREATMENT | SULFOXIDE METABOLITE | Experimental water-soluble prodrug compound | VACCINE | MOLECULES | LIVER FLUKE | TEGUMENTAL RESPONSES | COMPOUND-ALPHA | alpha | VETERINARY SCIENCES | PARASITOLOGY | Prodrugs - administration & dosage | Fascioliasis - veterinary | Parasite Egg Count | Sheep Diseases - parasitology | Solubility | Prodrugs - chemistry | Injections, Intramuscular | Anthelmintics - chemistry | Sheep Diseases - drug therapy | Prodrugs - adverse effects | Fasciola hepatica - drug effects | Animals | Fascioliasis - parasitology | Feces - parasitology | Fascioliasis - drug therapy | Sheep | Prodrugs - therapeutic use | Anthelmintics - isolation & purification | Anthelmintics - administration & dosage | Anthelmintics - therapeutic use | Drug Compounding - veterinary | Analysis | Adults
Fasciola hepatica | Experimental water-soluble prodrug compound alpha | bioisostere | anthelmintics | TRICLABENDAZOLE RESISTANCE | INFECTED CATTLE | EFFICACY | IN-VITRO TREATMENT | SULFOXIDE METABOLITE | Experimental water-soluble prodrug compound | VACCINE | MOLECULES | LIVER FLUKE | TEGUMENTAL RESPONSES | COMPOUND-ALPHA | alpha | VETERINARY SCIENCES | PARASITOLOGY | Prodrugs - administration & dosage | Fascioliasis - veterinary | Parasite Egg Count | Sheep Diseases - parasitology | Solubility | Prodrugs - chemistry | Injections, Intramuscular | Anthelmintics - chemistry | Sheep Diseases - drug therapy | Prodrugs - adverse effects | Fasciola hepatica - drug effects | Animals | Fascioliasis - parasitology | Feces - parasitology | Fascioliasis - drug therapy | Sheep | Prodrugs - therapeutic use | Anthelmintics - isolation & purification | Anthelmintics - administration & dosage | Anthelmintics - therapeutic use | Drug Compounding - veterinary | Analysis | Adults
Journal Article